Stromal Desmoplastic Reaction as a Predictive Factor for Lymph Node Metastasis in Medullary Thyroid Cancer

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAristotle University Of Thessaloniki

About this trial

This is a prospective multicenter observational study on medullary thyroid cancer , aiming to investigate the correlation of stromal desmoplastic reaction with tumor aggressiveness.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who underwent thyroidectomy for medullary thyroid cancer (total thyroidectomy) +/- central/lateral neck dissection

Sporadic medullary thyroid cancer

Disqualifiers

Age < 18 years

Hereditary medullary thyroid cancer cases

Patients that do not undergo central or lateral lymph node dissection

Patient unwillingness to participate in this study

Trial population

Patients with medullary thyroid cancer that will undergo surgery as curative method

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • lobectomy with lymph node dissection

    Procedure/Surgery

    This operation is the one suggested by the guidelines for medullary thyroid cancer

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Number of patients with absence of Desmoplastic stromal reaction and metastatic lymph node in central and lateral compartment

Number of patients with absence of Desmoplastic stromal reaction and metastatic lymph node in central and lateral compartment

Time frame
Perioperative/ From the end of the surgery to the pathology report results that characterizes this outcome

Secondary outcomes

1

Factors like baseline calcitonin levels, extrathyroidal extension, lymphovascular and capsular invasion that correlate with lymph node metastasis in medullary thyroid cancer

Factors like baseline calcitonin levels, extrathyroidal extension, lymphovascular and capsular invasion that correlate with lymph node metastasis in medullary thyroid cancer

Time frame
From baseline to up to 3 months postoperatively

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Aristotle University Of Thessaloniki

Lead sponsor

University of Cagliari

Collaborator

University of Pisa

Collaborator

Universita di Verona

Collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Collaborator

This trial is not recruiting at the moment. You can still explore other options: